[MDGL] YoY Quarter Result on 30-Sep-2013 [#Q3]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
04-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- 1.19%
YoY- -50.14%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 0 0 0 0 0 1,664 3,383 -
PBT -14,049 -17,628 -19,966 -22,515 -14,996 -12,734 -10,262 5.36%
Tax -11,991 0 0 0 0 0 31 -
NP -14,049 -17,628 -19,966 -22,515 -14,996 -12,734 -10,262 5.36%
Tax Rate - - - - - - - -
Total Cost 14,049 17,628 19,966 22,515 14,996 14,398 13,645 0.48%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -765.26 -303.34 -
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
EPS -1.59 -102.46 -6.61 -11.41 -8.65 -9.02 -8.89 -24.91%
EPS Diluted -1.59 -102.46 -6.61 -11.41 -8.65 -9.02 -8.89 -24.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.